ColleenConnPR

Global Head of Public Relations for @Cytiva. All tweets are my own. RT do not equal an endorsement.

[ColleenConnPR @pr_conn]

Navigating sustainability in biopharma? Tackling scope 3 emissions can be tough. Suppliers and biopharma companies need to collaborate more closely to make strides in sustainability. Check out our review: https://t.co/s7EfcbBkqI.

[ColleenConnPR @pr_conn]

Speeding up the delivery of therapeutics. How a leader in biotechnology is utilizing digital technology.

Read our paid post on The New York Times site https://t.co/M5Maf2aXvM

[ColleenConnPR @pr_conn]

Dive into the world of sustainability with my colleague Ryan Walker!

As Cytiva's Sustainability Programme Leader, Ryan spills the beans on our innovative strategies.

Read all about it here: https://t.co/DAn6dfpWko

[ColleenConnPR @pr_conn]

Amanda Halford, President Bioprocess at Cytiva, weighs in on the future of monoclonal antibodies. In 2024, the emphasis will remain on novel mAbs. https://t.co/W0S5jY0vTH

[ColleenConnPR @pr_conn]

We're into 2024 with a new CEO, Chris Riley. Dan Stanton is first out with an interview, where Chris shares some early thoughts about leading Cytiva into our next phase. https://t.co/QJfkxUuJeF

[ColleenConnPR @pr_conn]

Cytiva has opened a 33,000 square-foot manufacturing facility and experience center in Pune, India.

The facility will boost bioprocess vendor Cytiva’s production of equipment including tangential flow, virus filtration, and inactivation systems. https://t.co/dA3r2THMXW

[ColleenConnPR @pr_conn]

Christopher Long, Global Marketing Leader, Digital Solutions at Cytiva explores how digitalization will be the new norm in biomanufacturing. Digital and automation strategies are enabling companies to deliver medicines to patients faster. Read now! https://t.co/qdGgtXm4cd

[ColleenConnPR @pr_conn]

Niklas Jungnelius, Process Modeling Leader, shares how moving from batch to continuous manufacturing technologies does not come with any guarantee to improve your production, but implemented wisely, it has the potential to transform it. https://t.co/CT57G0xcg2

[ColleenConnPR @pr_conn]

Meet Cytiva's expert Susan Riley, showcased in BioPharm International's feature on scaling up biologic drug strategies. Dive into the article to uncover how companies can refine cell culture processes for monoclonal antibody production.

#mabs #cellculture https://t.co/wIAzBKoxB0

[ColleenConnPR @pr_conn]

The success of the mRNA vaccines during the pandemic led to explosive growth in lipid nanoparticle (LNP)-mediated drug delivery for therapeutics. Cytiva’s new NanoAssemblr commercial formulation system will help LNP developers scale up their projects.

https://t.co/M4WiAiho4g

[ColleenConnPR @pr_conn]

Emmanuel Abate talks about 2022 progress on our targets to ‘Designing in sustainability’. Find out more about sustainability at Cytiva: https://t.co/fRK2sp6jtW

[ColleenConnPR @pr_conn]

Back in May, Cytiva completed its integration with Pall Life Sciences, a move that CEO Emmanuel Ligner now describes as a “winning recipe” which has improved the company’s supply chain and fostered industry collaboration. https://t.co/tTSbGvovbC

[ColleenConnPR @pr_conn]

Read how the University of Limerick is using Cytiva's ÄKTA Start system in undergraduate labs to accelerate students' careers.

#cytiva
#ÄKTA https://t.co/MMk8gtJw0s

[ColleenConnPR @pr_conn]

DDW's Megan Thomas caught up with George White, General Manager, Product Management, Cell & Gene Therapy at Cytiva, to learn more about the company's insight into the CGT market. https://t.co/o0teW2me8p

[ColleenConnPR @pr_conn]

Joining my Cytiva colleague, Amanda Halford, in celebrating this new era for our organization and the wealth of new possibilities on the horizon for our customers and patients.

Learn more about the transition: https://t.co/M04pTJJmMb

#BetterTogether
#WeAreCytiva
#lifesciences

[ColleenConnPR @pr_conn]

Emmanuel Ligner, President and CEO of Cytiva and Danaher Group Executive, discusses the impact of the merger on the biopharma industry in the APAC region and the benefits for customers and stakeholders with BioPharma APAC. https://t.co/LdHHjpbNPm

[ColleenConnPR @pr_conn]

Emmanuel Ligner, President and CEO, Cytiva, shares how we are "better together" since our integration with Pall's life sciences business. https://t.co/VbSnWVkfxS

#WeAreCytiva

[ColleenConnPR @pr_conn]

Cytiva experts Scott Ripley, PhD, and Tracy Humphries discuss how RNA therapeutics will impact the development of genomic medicines. https://t.co/riRu6WVjaW

#RNA
#WeAreCytiva

[ColleenConnPR @pr_conn]

Emmanuel Ligner, President and CEO, Cytiva, discusses how combining with the life sciences business of Pall makes our organization better positioned to drive industry growth. https://t.co/Ix5sWPmK3D

#WeAreCytiva

[ColleenConnPR @pr_conn]

Cytiva is pioneering an innovative recyclable packaging solution to replace polystyrene through its Designing in Sustainability strategy. https://t.co/XzKfsMlX4o